Kanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedActivity from announced rounds
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients.